Alembic Pharmaceuticals on Thursday said its US arm has acquired Utility Therapeutics Ltd in a USD 12 million (over Rs 100 crore) deal to strengthen its presence in the American market.
The acquisition is being done by Alembic Pharmaceuticals, Inc, the company's US subsidiary, Alembic said in a statement.
Comments
Post a Comment